Patent · US Active

HCV NS4A/modified NS3 polypeptides and uses thereof

US10267803B2 · kind B2 · utility

0Cited by
6References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 22, 2015
Grant dateApr 23, 2019
Priority date
Expiry dateJun 22, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2469/20
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Modified hepatitis C virus polypeptides are described. The polypeptides include the HCV NS4a domain and modified NS3 domain. The polypeptides retain conformational epitopes. HCV immunoassays including the polypeptides are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.